Skip to Main Content

Paper Details

Next-Generation Sequencing-Based Assessment of JAK2, PD-L1, and PD-L2 Copy Number Alterations at 9p24.1 in Breast Cancer: Potential Implications for Clinical Management.
J Mol Diagn
20
2019
9p24, Breast Cancer, Cancer, JAK2, PD-L1, PD-L2, breast cancer, copy number alterations, stromal tumor infiltrating lymphocytes, triple, triple-negative breast cancer
Author NameAffiliation
José BaselgaMemorial Sloan Kettering Cancer Center
Michael F BergerMemorial Sloan Kettering Cancer Center
Marc LadanyiMemorial Sloan Kettering Cancer Center
  • 1 - 3

Datasets

Release 1.2